G004661
HPLC Analysis of Sibutramine Enantiomers on Astec® CHIROBIOTIC® V2
application for HPLC
Sign Into View Organizational & Contract Pricing
All Photos(1)
About This Item
technique(s)
HPLC: suitable
test parameters
column: CHIROBIOTIC V2, 25 cm x 4.6 mm I.D., 5 μm particles (15024AST)
mobile phase: 15 mM ammonium formate in methanol
flow rate: 1 mL/min
column temp.: 25 °C
detector: UV, 230 nm
injection: 10 μL
sample: 1 mg/mL in methanol
suitability
application for HPLC
application(s)
pharmaceutical (small molecule)
Analysis Note
Sibutramine, one of a few drugs approved for long-term treatment of obesity, is a chiral compound. The (R) enantiomer has the desired effect of reducing body weight and food intake, but the (S) enantiomer has the opposite effect: A perfect example of why chiral HPLC is important to pharmaceutical and clinical analysts. Astec® CHIROBIOTIC® V2 successfully separates sibutramine enantiomers, using a simple, MS-friendly mobile phase.
Legal Information
Astec is a registered trademark of Merck KGaA, Darmstadt, Germany
CHIROBIOTIC is a registered trademark of Sigma-Aldrich Co. LLC
Analyte
Description
Sibutramine hydrochloride monohydrate, ≥98% (HPLC), solid
analytical column
Product No.
Description
Pricing
Choose from one of the most recent versions:
Certificates of Analysis (COA)
Lot/Batch Number
Sorry, we don't have COAs for this product available online at this time.
If you need assistance, please contact Customer Support.
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.
Contact Technical Service